Display Settings:

Format

Send to:

Choose Destination

    Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):576-81. Epub 2003 Mar 6.

    Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.

    Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH.

    Division of Infectious Disease, Children's Memorial Hospital, Chicago, Ill, USA.

    OBJECTIVE: Coronary artery aneurysms are the major complication of Kawasaki disease (KD). Matrix metalloproteinases (MMPs) regulate remodeling and degradation of the extracellular matrix. We hypothesized that MMP-9 expression is increased in acute KD aneurysms when compared with KD nonaneurysmal arteries and arteries from control children. METHODS AND RESULTS: MMP-2, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1, and TIMP-2 were immunolocalized in coronary arteries from children with fatal acute KD and controls. In KD coronary aneurysms, MMP-2 expression was prominent in the thickened neointima and in endothelial cells of new capillaries in areas of angiogenesis. MMP-9 was absent in control coronary arteries but was expressed in coronary artery aneurysms, nonaneurysmal coronary and noncoronary arteries, and cardiac nerves in acute KD, without an increase in TIMP-1 expression. CONCLUSIONS: MMP-2 likely participates in remodeling of the arterial wall in acute KD, particularly in the processes of neointimal proliferation and angiogenesis. MMP-9 may play a role in the development of coronary aneurysms, but its expression is not confined to aneurysmal arteries. Systemic arterial expression of MMP-9 in acute KD, even in the absence of inflammatory changes in the vessel, suggests induction by a circulating factor, or possibly by an infectious agent with tropism for arterial tissue.

    PMID: 12692003 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read